CHEK2 and breast carcinoma: If we consider only mutations in genes that reached statistical significance in our analysis, (TP53, ATM, PALB2, BARD1, and truncating mutations in CHEK2), approximately 4.7% of BRCA negative FBC women have mutations in breast cancer susceptibility genes.